Cisplatin/pemetrexed or Carboplatin/pemetrexed + Placebo + DURVALUMAB

1 treatment and condition followed through the public trial records. Not medical advice. How a status is set

Treatments and conditions

Cisplatin/pemetrexed or Carboplatin/pemetrexed + Placebo + DURVALUMAB
Treatment and conditionWhere it standsTrials
Cisplatin/pemetrexed or Carboplatin/pemetrexed + Placebo + DURVALUMAB for adenocarcinoma of lungPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1